US Food and Drug Administration Regulations and Birth Defect Prevention: It's More Than Labeling

被引：0

作者：

Johnson, T. N. ^{[1
]}

机构：

[1] US FDA, Silver Spring, MD USA

来源：

BIRTH DEFECTS RESEARCH | 2018年 / 110卷 / 09期

关键词：

D O I：

暂无

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

S48

引用

页码：737 / 737

页数：1

共 50 条

[31] US Food and Drug Administration Updates
Sahin, L.
BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748
[32] Urokinase and the US food and drug administration
Ouriel, K
JOURNAL OF VASCULAR SURGERY, 1999, 30 (05) : 957 - 958
[33] Independence at the US Food and Drug Administration
不详
LANCET, 2006, 367 (9523): : 1630 - 1630
[34] Transparency at the US Food and Drug Administration
Califf, Robert M.
JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
[35] FOOD LABELING - ADA COMMENTS TO THE FOOD-AND-DRUG-ADMINISTRATION
不详
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1978, 73 (06) : 664 - 667
[36] Biosimilars according to Jordan Food and Drug Administration regulations
Abdelaziz, A. A.
ANNALES PHARMACEUTIQUES FRANCAISES, 2022, 80 (03): : 248 - 252
[37] Introduction to the new prescription drug labeling by the Food and Drug Administration
Lal, Renu
Kremzner, Mary
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (23) : 2488 - 2494
[38] The new US Food and Drug Administration pregnancy and lactation labeling rules: Their impact on clinical practice
Danesh, Melissa J.
Murase, Jenny E.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (02) : 310 - 311
[39] Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs
Naci, Huseyin
Guan, Xiaodong
Woloshin, Steven
Xu, Ziyue
Wagner, Anita K.
JAMA INTERNAL MEDICINE, 2021, 181 (11) : 1521 - 1522
[40] What's new on nutrition labeling at the United States Food and Drug Administration?
Brandt, MB
LeGault, LA
JOURNAL OF FOOD COMPOSITION AND ANALYSIS, 2003, 16 (03) : 383 - 393

← 1 2 3 4 5 →